YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A‐dependent DAPK3 degradation.

MLA

Bai, Xuesong, et al. “YTHDF2 Promotes Gallbladder Cancer Progression and Gemcitabine Resistance via M6A‐dependent DAPK3 Degradation.” Cancer Science, vol. 114, no. 11, Nov. 2023, pp. 4299–313. EBSCOhost, https://doi.org/10.1111/cas.15953.

APA

Bai, X., Chen, J., Zhang, W., Zhou, S., Dong, L., Huang, J., & He, X. (2023). YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A‐dependent DAPK3 degradation. Cancer Science, 114(11), 4299–4313. https://doi.org/10.1111/cas.15953

Chicago

Bai, Xuesong, Jiemin Chen, Wenqin Zhang, Shengnan Zhou, Liangbo Dong, Jianhao Huang, and Xiaodong He. 2023. “YTHDF2 Promotes Gallbladder Cancer Progression and Gemcitabine Resistance via M6A‐dependent DAPK3 Degradation.” Cancer Science 114 (11): 4299–4313. doi:10.1111/cas.15953.